Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Huot

Showing results (21-30 of 107) with videos related to

Pageof 11
Sort By:
The Neurologist|December 24, 2016
Movement Disorders Induced by the "Atypical" Antipsychotic AripiprazoleKarim Selfani, Valérie L Soland, Sylvain Chouinard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Additive effects of mGluR<sub>2</sub> positive allosteric modulation, mGluR<sub>2</sub> orthosteric stimulation and 5-HT<sub>2A</sub>R antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetStephen G Nuara, Jim C Gourdon, Shawn Maddaford, et al.
Journal of Chemical Neuroanatomy|April 24, 2024
Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brainEsther Kim, Imane Frouni, Judy Shaqfah, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 26, 2020
The mGlu<sub>2/3</sub> antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu<sub>2</sub> activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmosetStephen G Nuara, Adjia Hamadjida, Jim C Gourdon, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2017
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's diseaseAdjia Hamadjida, Stephen G Nuara, Jim C Gourdon, et al.
Radiology Case Reports|November 9, 2023
Metronidazole-induced encephalopathy in a patient with cirrhosisXinyu Ji, Ke Xuan Li, Leonardo Furtado Freitas, et al.
Biomedical Chromatography : BMC|June 10, 2022
Quantitative determination of LY-404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC-MRM/MSWoojin Kang, Fleur Gaudette, Dominique Bédard, et al.
Behavioural Pharmacology|January 5, 2021
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned ratCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
European Journal of Pharmacology|January 12, 2020
Ondansetron, a highly selective 5-HT<sub>3</sub> receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 8, 2021
Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmosetCynthia Kwan, Stephen G Nuara, Jim C Gourdon, et al.
Pageof 11

Showing results (21-30 of 107) with videos related to

Sort By:
Pageof 11
The Neurologist|December 24, 2016
Movement Disorders Induced by the "Atypical" Antipsychotic AripiprazoleKarim Selfani, Valérie L Soland, Sylvain Chouinard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Additive effects of mGluR<sub>2</sub> positive allosteric modulation, mGluR<sub>2</sub> orthosteric stimulation and 5-HT<sub>2A</sub>R antagonism on dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmosetStephen G Nuara, Jim C Gourdon, Shawn Maddaford, et al.
Journal of Chemical Neuroanatomy|April 24, 2024
Autoradiographic labelling of metabotropic glutamate type 2/3 receptors in the hemi-parkinsonian rat brainEsther Kim, Imane Frouni, Judy Shaqfah, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|April 26, 2020
The mGlu<sub>2/3</sub> antagonist LY-341,495 reverses the anti-dyskinetic and anti-psychotic effects of the mGlu<sub>2</sub> activators LY-487,379 and LY-354,740 in the MPTP-lesioned marmosetStephen G Nuara, Adjia Hamadjida, Jim C Gourdon, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2017
Trazodone alleviates both dyskinesia and psychosis in the parkinsonian marmoset model of Parkinson's diseaseAdjia Hamadjida, Stephen G Nuara, Jim C Gourdon, et al.
Radiology Case Reports|November 9, 2023
Metronidazole-induced encephalopathy in a patient with cirrhosisXinyu Ji, Ke Xuan Li, Leonardo Furtado Freitas, et al.
Biomedical Chromatography : BMC|June 10, 2022
Quantitative determination of LY-404,039, a metabotropic glutamate 2/3 receptor agonist, in rat plasma using chemical derivatization and HPLC-MRM/MSWoojin Kang, Fleur Gaudette, Dominique Bédard, et al.
Behavioural Pharmacology|January 5, 2021
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned ratCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
European Journal of Pharmacology|January 12, 2020
Ondansetron, a highly selective 5-HT<sub>3</sub> receptor antagonist, reduces L-DOPA-induced dyskinesia in the 6-OHDA-lesioned rat model of Parkinson's diseaseCynthia Kwan, Imane Frouni, Dominique Bédard, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 8, 2021
Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmosetCynthia Kwan, Stephen G Nuara, Jim C Gourdon, et al.
Pageof 11